Wyatt Investment Research login

 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
 
 

Tag - IVC

 

 
Wyatt Research Staff

Ashland, Williams Controls and First M&F among 52-week lows

Ashland Inc. (Nasdaq:ASH), Williams Controls Inc. (Nasdaq:WMCO) and First M&F Corp. (Nasdaq:FMFC) are among the new 52-week lows in Monday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Bancorp Rhode Island Inc. (Nasdaq:BARI), Heckmann Corp. (Nasdaq:HEK), Cheviot Financial Corp. (Nasdaq:CHEV), Invacare Corp. (Nasdaq:IVC), Northwest Bancorp Inc. (Nasdaq:NWSB) and Northeast Community Bancorp Inc. (Nasdaq:NECB).
[ More » ]
Jennifer Schonberger

Invacare Corp.: A safe haven for capital

As the credit crisis continues to roil markets, restless investors are on the lookout for safe havens to deploy capital. Enter Invacare Corp. (NYSE:IVC), which operates in the medical equipment space oasis, manufacturing such items as power and custom manual wheelchairs, home-care beds and oxygen concentrators for home-health care, retail and government internationally.

Given that Invacare operates in the health-care sector, it doesn’t experience earnings erosion due to adverse macroeconomic trends. As such, money has been funneling into this sector and this stock. Six new positions were initiated in the last three months, while none sold out. 

New legislation passed in July will assist in avoiding disruptions to patient service and provide stability, providing even more demand that is strong at home and abroad. Organic sales grew 7.8% in the second quarter, driven by sales in Invacare’s North American home medical equipment market and strong demand in Europe. For the second quarter ended June 30, 2008, sales were up 13.7% to $447.2 million, compared with $393.3 million in 2007. Non GAAP net income increased to $7 million, or $0.22 per share, compared with non GAAP net income of $4.3 million, or $0.14 per share.

Aside from an inherently strong business, the company is streamlining costs and reducing net interest expense as it pays off its debt, which is favorable in this financing climate.

Before you take the plunge, though, be aware that Invacare is grappling with increased freight and higher commodity costs as well as reimbursement pressures in Europe. To combat that, the company is selectively increasing prices in all segments and . . .
[ More » ]